All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis

Clin Gastroenterol Hepatol. 2020 Jan;18(1):51-53. doi: 10.1016/j.cgh.2019.07.020. Epub 2019 Jul 16.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Cholangitis, Sclerosing*
  • Humans
  • Inflammatory Bowel Diseases*

Substances

  • Antibodies, Monoclonal, Humanized
  • vedolizumab